Warning: The NCBI web site requires JavaScript to function. more...
The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis.
Fishman P, Bar-Yehuda S, Madi L, Rath-Wolfson L, Ochaion A, Cohen S, Baharav E.
Arthritis Res Ther. 2006;8(1):R33. Epub 2006 Jan 13.
Related citations
IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis.
Rath-Wolfson L, Bar-Yehuda S, Madi L, Ochaion A, Cohen S, Zabutti A, Fishman P.
Clin Exp Rheumatol. 2006 Jul-Aug;24(4):400-6.
The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-kappaB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats.
Ochaion A, Bar-Yehuda S, Cohen S, Amital H, Jacobson KA, Joshi BV, Gao ZG, Barer F, Patoka R, Del Valle L, Perez-Liz G, Fishman P.
Biochem Pharmacol. 2008 Aug 15;76(4):482-94. Epub 2008 Jun 17.
Antiinflammatory effect of A3 adenosine receptor agonists in murine autoimmune arthritis models.
Baharav E, Bar-Yehuda S, Madi L, Silberman D, Rath-Wolfson L, Halpren M, Ochaion A, Weinberger A, Fishman P.
J Rheumatol. 2005 Mar;32(3):469-76.
Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression.
Ochaion A, Bar-Yehuda S, Cohn S, Del Valle L, Perez-Liz G, Madi L, Barer F, Farbstein M, Fishman-Furman S, Reitblat T, Reitblat A, Amital H, Levi Y, Molad Y, Mader R, Tishler M, Langevitz P, Zabutti A, Fishman P.
Arthritis Res Ther. 2006;8(6):R169.
Activation of adenosine A3 receptor suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of PI 3-kinase/Akt and NF-kappaB activation in murine BV2 microglial cells.
Lee JY, Jhun BS, Oh YT, Lee JH, Choe W, Baik HH, Ha J, Yoon KS, Kim SS, Kang I.
Neurosci Lett. 2006 Mar 20;396(1):1-6. Epub 2005 Dec 1.
The anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis.
Bar-Yehuda S, Silverman MH, Kerns WD, Ochaion A, Cohen S, Fishman P.
Expert Opin Investig Drugs. 2007 Oct;16(10):1601-13. Review.
Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-kappaB signalling pathway in thyroid cancer cells.
Morello S, Sorrentino R, Porta A, Forte G, Popolo A, Petrella A, Pinto A.
J Cell Physiol. 2009 Nov;221(2):378-86.
Overexpression of A3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: involvement of nuclear factor-kappaB in mediating receptor level.
Madi L, Cohen S, Ochayin A, Bar-Yehuda S, Barer F, Fishman P.
J Rheumatol. 2007 Jan;34(1):20-6.
Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling.
Lee HS, Chung HJ, Lee HW, Jeong LS, Lee SK.
Immunobiology. 2011 Sep;216(9):997-1003. Epub 2011 Apr 7.
Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist.
Fishman P, Bar-Yehuda S, Ardon E, Rath-Wolfson L, Barrer F, Ochaion A, Madi L.
Anticancer Res. 2003 May-Jun;23(3A):2077-83.
Induction of apoptosis by A3 adenosine receptor agonist N-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism.
Mlejnek P, Dolezel P.
Acta Physiol (Oxf). 2010 Jun;199(2):171-9. Epub 2010 Jan 30.
A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition.
Madi L, Bar-Yehuda S, Barer F, Ardon E, Ochaion A, Fishman P.
J Biol Chem. 2003 Oct 24;278(43):42121-30. Epub 2003 Jul 15.
Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation.
Morello S, Petrella A, Festa M, Popolo A, Monaco M, Vuttariello E, Chiappetta G, Parente L, Pinto A.
Cancer Biol Ther. 2008 Feb;7(2):278-84. Epub 2007 Nov 14.
A3 adenosine receptor agonist potentiates natural killer cell activity.
Harish A, Hohana G, Fishman P, Arnon O, Bar-Yehuda S.
Int J Oncol. 2003 Oct;23(4):1245-9.
A3 adenosine receptor as a target for cancer therapy.
Fishman P, Bar-Yehuda S, Madi L, Cohn I.
Anticancer Drugs. 2002 Jun;13(5):437-43. Review.
Induction of an antiinflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment.
Bar-Yehuda S, Rath-Wolfson L, Del Valle L, Ochaion A, Cohen S, Patoka R, Zozulya G, Barer F, Atar E, Piña-Oviedo S, Perez-Liz G, Castel D, Fishman P.
Arthritis Rheum. 2009 Oct;60(10):3061-71.
A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells.
Lee EJ, Min HY, Chung HJ, Park EJ, Shin DH, Jeong LS, Lee SK.
Biochem Pharmacol. 2005 Sep 15;70(6):918-24.
Agonists to the A3 adenosine receptor induce G-CSF production via NF-kappaB activation: a new class of myeloprotective agents.
Bar-Yehuda S, Madi L, Barak D, Mittelman M, Ardon E, Ochaion A, Cohn S, Fishman P.
Exp Hematol. 2002 Dec;30(12):1390-8.
A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis.
Lee HT, Kim M, Joo JD, Gallos G, Chen JF, Emala CW.
Am J Physiol Regul Integr Comp Physiol. 2006 Oct;291(4):R959-69. Epub 2006 May 25.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on